Nova Mentis Announces Closing of Non-Brokered Financing
Ryan Allway March 15th, 2022 Psychedelics, Top News VANCOUVER, BC, March 15, 2022 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased to announce that it has completed a non-brokered private... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )